Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SI-6603 (Condoliase) in Lumbar Disc Herniation
NCT02421601Phase 3Completed
- Sponsor
- Seikagaku Corporation
- Start
- Mar 2015
- Primary completion
- Feb 2018
- Modality
- Replacement Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of condoliase in lumbar disc herniation (LDH), sponsored by Seikagaku Corporation. Started Mar 2015; status: completed.
02
Drugs
condoliase
03
Conditions
lumbar disc herniation (LDH)
Beyond the preview
Go deeper on NCT02421601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421601.